BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 12099190)

  • 21. Patients' resistance to risk information in genetic counseling for BRCA1/2.
    Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
    Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations.
    d'Agincourt-Canning L; Baird P
    Crit Rev Oncol Hematol; 2006 May; 58(2):114-23. PubMed ID: 16600617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP
    Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the breast cancer education and risk assessment program.
    Snyder LA; Soballe DB; Lahl LL; Nehrebecky ME; Soballe PW; Klein PM
    Oncol Nurs Forum; 2003; 30(5):803-8. PubMed ID: 12949593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].
    Radulović S; Branković-Magić M; Janković R; Ristanović M
    Srp Arh Celok Lek; 2003; 131(7-8):345-50. PubMed ID: 14692152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
    Metcalfe A; Werrett J; Burgess L; Clifford C
    Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychological aspects of predictive genetic diagnosis in breast and ovarian carcinoma].
    Tiefensee I; Klusmann D
    Psychother Psychosom Med Psychol; 1998; 48(9-10):369-74. PubMed ID: 9785966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics and the multidisciplinary breast center.
    Peters JA; Rubinstein WS
    Surg Oncol Clin N Am; 2000 Apr; 9(2):367-96. PubMed ID: 10757850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
    Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
    Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic risk assessment for breast and ovarian cancer.
    O'Rourke Tiffen J; Pfeifer K; Fishman DA
    Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
    Van Riper M; McKinnon WC
    J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
    Macdonald KG; Doan B; Kelner M; Taylor KM
    CMAJ; 1996 Feb; 154(4):457-64. PubMed ID: 8630835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
    Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
    Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
    Brunsvold AN; Wung SF; Merkle CJ
    J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer genetics in primary care.
    Culler D; Grimes SJ; Acheson LS; Wiesner GL
    Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing hereditary breast cancer risk.
    Cancer Pract; 1999; 7(6):279-84. PubMed ID: 10732524
    [No Abstract]   [Full Text] [Related]  

  • 40. Awareness of genetic testing for breast cancer risk among women with a family history of breast cancer: effect of women's information sources on their awareness.
    Meischke H; Bowen D; Kuniyuki A
    Cancer Detect Prev; 2001; 25(4):319-27. PubMed ID: 11531008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.